BMSEED: News
BMSEED is committed to driving innovation and creating a positive impact on the biomedical research community. Our mission is to develop and provide state-of-the-art devices that empower researchers, biomedical scientists, and healthcare professionals to push the boundaries of scientific discovery. Through our cutting-edge technologies, including stretchable microelectrode arrays and advanced cell-stretching systems, we aim to facilitate more effective and efficient biomedical studies. Our focus is on supporting the advancement of biomedical science, fostering collaboration, and enabling groundbreaking research that can transform healthcare. Whether through partnerships, product innovation, or knowledge sharing, BMSEED is dedicated to shaping the future of biomedicine.
Reach Out to BMSEED
Contact us at BMSEED if you're interested in the MEASSuRE system. Our team will walk you through how this tool can support and enhance your research.
BMSEED Awarded Fast Track SBIR Grant from NIH
BMSEED was awarded a Fast Track SBIR grant from NIH to develop and commercialize a microfluidic chip-based platform for modeling Alzheimer’s disease and Alzheimer’s disease related dementias (AD/ADRD) for preclinical in vitro mechanistic studies and drug testing.
Dunn Labortechnik is now BMSEED's Distributor for Europe
Dr. Hamza Mohammed from Dunn Labortechnik exhibiting BMSEED’s MEASSuRE platform at the TERMIS conference in Krakau, Poland.
BMSEED files non-provisional patent application for novel peripheral nerve interface
The mcPNI enables reliable, long-term neuromodulation in small peripheral nerves, and integrates a 2-photon 3D printed microclip with BMSEED’s stretchable microelectrode array (sMEA) technology.
BMSEED Chooses Intellectual Property Law Firm BSKB
BMSEED was recently awarded $50,000 from the NIH Small Business Phase II Technical and Business Assistance (TABA) Consulting Services program with the goal to strengthen the company’s IP portfolio.
BMSEED Completed the NIH I-Corps Program
BMSEED has completed the intensive 2022 NIH I-Corps program after 105 total interviews!
BMSEED Accepted to the NIH I-Corps Program
This will be BMSEED’s second time participating in the NIH I-Corps program.
BMSEED Accepted to NIH TABA Consulting Services Program
BMSEED was awarded consulting services for intellectual property through the TABA Consulting Services Program.
BMSEED Selected as FINALIST in 2021 Arizona Innovation Challenge
BMSEED is one of 15 finalists selected for the 2021 Arizona Innovation Challenge.
BMSEED Selected as Semifinalist in 2021 Arizona Innovation Challenge
BMSEED is one of 25 semifinalists selected for the 2021 Arizona Innovation Challenge.
BMSEED Awarded Phase I SBIR Grant from NIH
BMSEED recieved a Phase I SBIR award from the NIH for the commercialization of an organoid pocket microelectrode arrays.
BMSEED Exhibiting at 2021 National Neurotrauma Society Virtual Symposium
BMSEED will present at the 2021 NNS virtual symposium in July.
BMSEED Accepted as FINALIST in Fall 2020 Digital Resi Innovation Challenge
BMSEED will be pitching at the virtual Digital Resi Innovation Challenge from Sept 14-16, 2020.
BMSEED Pitching at 2020 Venture Café Cambridge Shark Tank Competition
BMSEED will pitch at the 2020 Venture Café Cambridge in the virtual Shark Tank Pitching Competition.
BMSEED Featured in the Arizona Republic
The Arizona Republic highlights the three Phoenix startups competing in the 2020 Bio International Startup Stadium contest: BMSEED, i-calQ, and Equus Innovations.
BMSEED in the Phoenix Spotlight
BMSEED is highlighted by the City of Phoenix for its participation in the virtual Bio International organization’s 2020 Startup Stadium.
BMSEED Partnering with BU to Develop Nanoclip Peripheral Nerve Interface
BMSEED is partnering with Boston University to develop a nanoclip peripheral nerve interface (ncPNI) for more biomechanically compatible neuroprostheses in fine nerve tissues.
BMSEED Accepted as Finalist for Start-Up Stadium at 2020 BIO International Convention
BMSEED is one of three Phoenix finalists for the 2020 Start-Up Stadium Program as part of BIO Digital.
BMSEED Accepted as Finalist in 2020 Venture Madness
BMSEED is one of 27 finalists in the 2020 Venture Madness business competition organized by Invest Southwest.
BMSEED Accepted to 2019/2020 NIH Commercialization Accelerator Program (CAP)
BMSEED is one of 80 companies accepted to the 2019/2020 cohort of the NIH Commercialization Accelerator Program (CAP).
BMSEED Presenting at 2019 Neurotrauma Meeting
BMSEED will present at the 2019 Society for Neurotrauma meeting in Pittsburgh, PA.